AUROBINDO PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,241 INR | -0.17% |
|
-1.42% | +14.49% |
| 06-05 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
| 05-27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUROBINDO PHARMA | Other Pharmaceuticals | -0.17% | -1.42% | +14.49% | +81.98% | +106.01% | 8.71B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AUROPHARMA Stock
- Charts Aurobindo Pharma
- Comparison Chart
